作者
Stella Victorelli,Hanna Salmonowicz,James Chapman,Hélène Martini,Maria Grazia Vizioli,Joel S. Riley,Catherine Cloix,Ella Hall-Younger,Jair M. Espindola-Netto,Diana Jurk,Anthony B. Lagnado,Lilian Sales Gomez,Joshua N. Farr,Dominik Saul,Rebecca Reed,George Kelly,Madeline Eppard,Laura C. Greaves,Zhixun Dou,Nicholas E. Pirius,Karolina Szczepanowska,Rebecca A. Porritt,Huijie Huang,Timothy Y. Huang,Derek A. Mann,Cláudio A. Masuda,Sundeep Khosla,Haiming Dai,Scott H. Kaufmann,Emmanouil Zacharioudakis,Evripidis Gavathiotis,Nathan K. LeBrasseur,Xue Lei,Alva G. Sainz,Viktor I. Korolchuk,Peter D. Adams,Gerald S. Shadel,Stephen W. G. Tait,João F. Passos
摘要
Abstract Senescent cells drive age-related tissue dysfunction partially through the induction of a chronic senescence-associated secretory phenotype (SASP) 1 . Mitochondria are major regulators of the SASP; however, the underlying mechanisms have not been elucidated 2 . Mitochondria are often essential for apoptosis, a cell fate distinct from cellular senescence. During apoptosis, widespread mitochondrial outer membrane permeabilization (MOMP) commits a cell to die 3 . Here we find that MOMP occurring in a subset of mitochondria is a feature of cellular senescence. This process, called minority MOMP (miMOMP), requires BAX and BAK macropores enabling the release of mitochondrial DNA (mtDNA) into the cytosol. Cytosolic mtDNA in turn activates the cGAS–STING pathway, a major regulator of the SASP. We find that inhibition of MOMP in vivo decreases inflammatory markers and improves healthspan in aged mice. Our results reveal that apoptosis and senescence are regulated by similar mitochondria-dependent mechanisms and that sublethal mitochondrial apoptotic stress is a major driver of the SASP. We provide proof-of-concept that inhibition of miMOMP-induced inflammation may be a therapeutic route to improve healthspan.